Tokyo, Nov. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059891) titled 'A study to evaluate the safety of excessive consumption of the test product: a randomized, placebo-controlled, double-blind, parallel-group comparison study' on Nov. 26.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - UCC UESHIMA COFFEE CO., LTD.
Condition:
Condition - Healthy Japanese
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To verify the safety of consuming five times the regular daily consumption of the test produc...